Avalo Therapeutics (AVTX) Receivables - Net (2016 - 2023)
Avalo Therapeutics (AVTX) recorded Receivables - Net of $38,000 in Q2 2023, down 95.8% from $900,000 a year earlier.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Receivables - Net (2016 - 2023) Analysis & Trends
At the end of FY2021, Avalo Therapeutics reported Receivables - Net of $1.06 million, down 51.3% from FY2020.
- Annual Receivables - Net has a five-year compound annual growth rate of 51.6% (FY2016 to FY2021).
- Across earlier years, Receivables - Net came in at $2.18 million in FY2020 (+117.3%), $1 million in FY2019 (+21.8%), $822,327 in FY2018 (-72.0%) and $2.94 million in FY2017.
- The Q2 2023 figure is the lowest quarterly Receivables - Net in data going back to Q4 2016.
- Peak year-over-year performance for Receivables - Net in the last five years was growth of 117.3% in Q4 2020, against a decline of 95.8% in Q2 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Avalo Therapeutics | 533.82 Mn | -158.40 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 38,000.00 |
| Sep 30, 2022 | 800,000.00 |
| Jun 30, 2022 | 900,000.00 |
| Mar 31, 2022 | 938,000.00 |
| Dec 31, 2021 | 1.06 Mn |
| Sep 30, 2021 | 1.44 Mn |
| Jun 30, 2021 | 4.12 Mn |
| Mar 31, 2021 | 3.13 Mn |
| Dec 31, 2020 | 2.18 Mn |
| Sep 30, 2020 | 1.67 Mn |
| Jun 30, 2020 | 2.03 Mn |
| Mar 31, 2020 | 2.19 Mn |
| Dec 31, 2019 | 1.00 Mn |
| Sep 30, 2019 | 4.96 Mn |
| Jun 30, 2019 | 2.86 Mn |
| Mar 31, 2019 | 2.72 Mn |
| Dec 31, 2018 | 822,327.00 |
| Sep 30, 2018 | 3.01 Mn |
| Jun 30, 2018 | 3.31 Mn |
| Mar 31, 2018 | 2.83 Mn |
API Access
Avalo Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();